<bill session="108" type="sr" number="398" updated="2023-01-14T22:48:24Z">
  <state datetime="2004-07-06">REFERRED</state>
  <status>
    <introduced datetime="2004-07-06"/>
  </status>
  <introduced datetime="2004-07-06"/>
  <titles>
    <title type="display">A resolution expressing the sense of the Senate on promoting initiatives to develop an HIV vaccine.</title>
    <title type="official" as="introduced">A resolution expressing the sense of the Senate on promoting initiatives to develop an HIV vaccine.</title>
  </titles>
  <sponsor bioguide_id="L000504"/>
  <cosponsors>
    <cosponsor bioguide_id="B000468" joined="2004-07-21"/>
    <cosponsor bioguide_id="D000294" joined="2004-07-22"/>
    <cosponsor bioguide_id="D000563" joined="2004-07-21"/>
    <cosponsor bioguide_id="E000285" joined="2004-07-21"/>
    <cosponsor bioguide_id="F000062" joined="2004-07-22"/>
    <cosponsor bioguide_id="L000123" joined="2004-07-21"/>
    <cosponsor bioguide_id="S000770" joined="2004-07-21"/>
  </cosponsors>
  <actions>
    <action datetime="2004-07-06">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2004-07-06">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S7583"/>
    </action>
    <action datetime="2004-07-06" state="REFERRED">
      <text>Referred to the Committee on Foreign Relations.</text>
      <reference ref="CR S7582-7583" label="text of measure as introduced"/>
    </action>
  </actions>
  <committees>
    <committee code="SSFR" name="Senate Foreign Relations" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="International affairs"/>
    <term name="AIDS (Disease)"/>
    <term name="Canada"/>
    <term name="Charities"/>
    <term name="Commerce"/>
    <term name="Communication in medicine"/>
    <term name="Communication in science"/>
    <term name="Conferences"/>
    <term name="East Asia"/>
    <term name="Economic assistance"/>
    <term name="Europe"/>
    <term name="Foreign leaders"/>
    <term name="France"/>
    <term name="Germany"/>
    <term name="Gifts"/>
    <term name="Government Operations and Politics"/>
    <term name="Health"/>
    <term name="Health planning"/>
    <term name="Human immunodeficiency viruses"/>
    <term name="Information networks"/>
    <term name="Information technology"/>
    <term name="International cooperation"/>
    <term name="International cooperation in science"/>
    <term name="Italy"/>
    <term name="Japan"/>
    <term name="Medical research"/>
    <term name="Pharmaceutical research"/>
    <term name="Product development"/>
    <term name="Public-private partnerships"/>
    <term name="Research and development"/>
    <term name="Research and development facilities"/>
    <term name="Russia"/>
    <term name="Science, Technology, Communications"/>
    <term name="Scientists"/>
    <term name="Social Welfare"/>
    <term name="Strategic planning"/>
    <term name="United Kingdom"/>
    <term name="Vaccines"/>
    <term name="World health"/>
  </subjects>
  <amendments/>
  <summary date="2004-09-16T14:14:46Z" status="Introduced in Senate">Expresses the sense of the Senate that the President should: (1) mobilize necessary economic and scientific support to establish a Global HIV Vaccine Enterprise (a virtual consortium to accelerate human immunodeficiency virus (HIV) vaccine development by enhancing coordination, information sharing, and collaboration globally); (2) urge members of the Group of Eight (Canada, France, Germany, Italy, Japan, Russia, the United Kingdom, and the United States) to garner support from their own communities for the development of an HIV vaccine; and (3) establish a second vaccine research and development center in the United States.

Expresses the sense of the Senate that such countries should: (1) leverage financial contributions from the international philanthropic community to provide funding to promote the development of an HIV vaccine; (2) include the scientific and political leadership of the countries most affected by HIV and acquired immune deficiency syndrome (AIDS) pandemic; and (3) develop a plan for furthering such efforts at their June 2005 meeting.

Urges the President to generate global support for the establishment of a Global HIV Vaccine Enterprise by carrying out an initiative that includes: (1) coordinating and partnering with member countries, the private sector, and other countries; (2) encouraging Group of Eight countries to act swiftly to mobilize resources; (3) following a strategic plan to prioritize the challenges to be addressed, to coordinate research and product development, and to encourage greater use of information-sharing networks and technologies; and (4) encouraging the establishment of coordinated global HIV vaccine development centers.</summary>
</bill>
